marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Teva Pharmaceutical Industries Limited Cash Flow 2011-2024 | TEVA
Annual Cash Flow Teva Pharmaceutical Industries Limited
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
1.37 B | 1.59 B | 798 M | 1.22 B | 748 M | 2.45 B | 2.22 B | 3.89 B | 5.54 B | 5.13 B | 3.24 B | 4.57 B | 4.13 B |
Depreciation & Amortization |
1.15 B | 1.31 B | 1.33 B | 1.56 B | 1.72 B | 1.84 B | 2.11 B | 1.52 B | 1.31 B | 1.51 B | 1.64 B | 1.71 B | 1.07 B |
Accounts Payables |
2.6 B | 1.89 B | 1.69 B | 1.76 B | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3.41 B | 3.7 B | 4.53 B | 4.58 B | 5.68 B | 5.82 B | 7.13 B | 7.52 B | 5.35 B | 5.41 B | 5.34 B | 5.57 B | 6.21 B |
Total Inventories |
4.02 B | 3.83 B | 3.82 B | 4.4 B | 4.42 B | 4.73 B | 4.92 B | 4.95 B | 3.97 B | 4.37 B | 5.05 B | 5.5 B | 5.01 B |
All numbers in USD currency
Quarterly Cash Flow Teva Pharmaceutical Industries Limited
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
693 M | 103 M | -124 M | 5 M | 324 M | -145 M | - | 543 M | 123 M | -49 M | - | 342 M | - | -405 M | - | 885 M | 578 M | 305 M | - | 210 M | -115 M | 112 M | - | 2.08 B | 1.66 B | 1.5 B | - | 1.37 B | 571 M | 136 M | - | - | - | 1.38 B | - | - | - | 1.35 B | - | - | - | 898 M | - | - | - | 1.1 B | - | - | - | 756 M | - | - | - | 900 M |
Depreciation & Amortization |
259 M | 259 M | 272 M | 283 M | 300 M | 304 M | - | 321 M | 358 M | 323 M | - | 1.01 B | 173 M | 376 M | - | 1.16 B | 781 M | 399 M | - | 1.31 B | 893 M | 443 M | - | 1.46 B | 986 M | 507 M | - | 1.58 B | 1.06 B | 480 M | - | - | - | 305 M | - | - | - | 335 M | - | - | - | 404 M | - | - | - | 387 M | - | - | - | 519 M | - | - | - | 266 M |
Accounts Payables |
2.37 B | 2.37 B | 2.44 B | 2.28 B | 2.51 B | 2.38 B | 1.89 B | 1.64 B | - | 1.75 B | 1.69 B | 1.51 B | 1.55 B | 1.69 B | 1.76 B | 1.76 B | 1.76 B | 1.76 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3.46 B | 3.77 B | 3.46 B | 3.38 B | 3.54 B | 3.44 B | 3.7 B | 3.73 B | - | 4.25 B | 4.53 B | 4.05 B | 4.49 B | 4.57 B | 4.58 B | 4.58 B | 4.58 B | 4.58 B | 5.68 B | 5.68 B | 5.68 B | 5.68 B | 5.82 B | 5.82 B | 5.82 B | 5.82 B | 7.13 B | 7.13 B | 7.13 B | 7.13 B | 7.52 B | 8.07 B | 5.37 B | 5.19 B | 5.35 B | 5.28 B | 5.57 B | 5.51 B | 5.41 B | 5.41 B | 5.39 B | 5.28 B | 5.34 B | 5.19 B | 5.3 B | 5.42 B | 5.57 B | 5.78 B | 5.43 B | 6.06 B | 6.21 B | 5.6 B | 5.47 B | 5.58 B |
Total Inventories |
3.96 B | 3.93 B | 3.95 B | 4.05 B | 4.11 B | 4.12 B | 3.83 B | 3.86 B | - | 4.01 B | 3.82 B | 4.17 B | 4.36 B | 4.41 B | 4.4 B | 4.4 B | 4.4 B | 4.4 B | 4.42 B | 4.42 B | 4.42 B | 4.42 B | 4.73 B | 4.73 B | 4.73 B | 4.73 B | 4.92 B | 4.92 B | 4.92 B | 4.92 B | 4.95 B | 5.35 B | 3.92 B | 3.96 B | 3.97 B | 4.09 B | 4.23 B | 4.17 B | 4.37 B | 4.59 B | 4.94 B | 4.98 B | 5.05 B | 5.24 B | 5.33 B | 5.38 B | 5.5 B | 5.46 B | 5.29 B | 5.33 B | 5.01 B | 4.67 B | 4.46 B | 4.22 B |
All numbers in USD currency